Mgr. Veronika VOJÁČKOVÁ
Telefon:
585634914
E-mail:
Pracoviště:
Katedra experimentální biologie
Org. jednotka:
Přírodovědecká fakulta
Adresa:
Šlechtitelů 27 A (hlavní budova)
Místnost:
3.22
Pracovní zařazení:
Vědecký pracovník
VYBRANÉ PUBLIKACE
Peřina M., Börzsei R., Ágoston H., Vojáčková V., Jorda R.
Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES.
2024.
(ČLÁNEK)
ČLÁNEK
Škerlová J., Krejčiříková V., Peřina M., Vojáčková V., Kryštof V., Jorda R.
CDK2-based CDK7 mimic as a tool for structural analysis: Biochemical validation and crystal structure with SY5609.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.
2025.
Peřina M., Kiss MA., Bělíček J., Vojáčková V., Veselá D., Jorda R.
Isoxazole-Based Compounds Targeting the Taxane-Binding Site of Tubulin.
ARCHIV DER PHARMAZIE.
2025.
Markuliak M., Kos D., Vojáčková V., Kryštof V., Jampílek J.
Preparation and biological activity of isoperrottetin A and its phosphonium salts derivatives.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES.
2025.
Kos J., Strhársky T., Tosso R., Vojáčková V., Kryštof V., Jampílek J.
Trifluoromethylcinnamanilides – Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum.
BIOORGANIC CHEMISTRY.
2025.
Cabezas D., Delgado T., Sepúlveda G., Krňávková P., Vojáčková V., Kryštof V., Strnad M., Mella J.
3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib.
Pharmaceuticals.
2025.
Moradi M., Mousavi A., Řezníčková E., Peřina M., Vojáčková V., Jorda R., Grúz J., Kryštof V., Foroumadi A.
Identification of furo[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazole derivatives as novel FLT3-ITD inhibitors.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.
2024.
Delgado T., Veselá D., Dostálová H., Kryštof V., Vojáčková V., Jorda R., Strnad M., Salas CO.
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs.
Pharmaceutics.
2024.
Moreira TM., Manuel DM., Rosa J., Vojáčková V., Jorda R., Nuno MX.
Synthesis and Antiproliferative Evaluation of D-Glucuronamide-Based Nucleosides and (Triazolyl)methyl Amide-Linked Pseudodisaccharide Nucleosides.
ChemMedChem.
2024.
Varvuolytė G., Řezníčková E., Bieliauskas A., Vojáčková V., Opichalová A., Žukauskaite A., Kryštof V.
Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles.
ARCHIV DER PHARMAZIE.
2024.
Varvuloitė G., Řezníčková E., Krikštolė S., Malina L., Vojáčková V., Duben Z., Kolářová H., Žukauskaite A., Kryštof V., Šačkus A.
Synthesis and photo-induced anticancer activity of new 2-phenylethenyl-1H-benzo[e]indole dyes.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.
2024.
Ganai AM., Pathan TK., Mohite SB., Vojáčková V., Řezníčková E., Kozlanská K., Kryštof V.
Design and synthesis of novel 1,2,4-triazolo[4,3-b]pyridazine derivatives with anti-cancer activity.
JOURNAL OF MOLECULAR STRUCTURE.
2023.
Břehová P., Řezníčková E., Škach K., Jorda R., Vojáčková V., Kovalová M., Kinnertová M., Gucký T., Kryštof V.
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.
JOURNAL OF MEDICINAL CHEMISTRY.
2023.
Shaldam MA., Veselá D., El-Haggar R., Vojáčková V., Kryštof V.
2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.
2023.
Ganai AM., Pathan TK., Merugu SR., Kozlanská K., Vojáčková V., Kryštof V.
Development of pyrimidine-cinnamamide hybrids as potential anticancer agents: A rational design approach.
JOURNAL OF MOLECULAR STRUCTURE.
2022.
Barghash RF., Eldehna WM., Kovalová M., Vojáčková V., Kryštof V., Abdel-Aziz HA.
One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.
2022.
Fortuna A., Gonçalves-Pereira R., Costa PJ., Jorda R., Vojáčková V., Gonzalez G.
Synthesis and Exploitation of the Biological Profile of Novel Guanidino Xylofuranose Derivatives.
ChemMedChem.
2022.
Razmienė B., Vojáčková V., Řezníčková E., Malina L., Kubala M., Bajgar R., Kolářová H., Žukauskaite A., Kryštof V.
Synthesis of N-aryl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-amines and their photodynamic properties in the human skin melanoma cell line G361.
BIOORGANIC CHEMISTRY.
2022.
Jorda R., Havlíček L., Peřina M., Vojáčková V., Pospíšil T., Grúz J., Strnad M., Kryštof V.
3,5,7-Substituted Pyrazolo[4,3-d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders.
JOURNAL OF MEDICINAL CHEMISTRY.
2022.
Rouchal M., Rudolfová J., Kryštof V., Vojáčková V.
Adamantane-Substituted Purines and Their beta-Cyclodextrin Complexes: Synthesis and Biological Activity.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
2021.
Jorda R., Molitorová V., Vojáčková V., Řezníčková E., Kryštof V.
Pseudopeptides with aldehyde or vinylsulfone warheads: Synthesis and antiproteasomal activity.
BIOORGANIC CHEMISTRY.
2021.
Dayal N., Řezníčková E., Hernandez DE., Peřina M., Vojáčková V., Kryštof V., Jorda R.
3H-Pyrazolo[4,3-f]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo.
JOURNAL OF MEDICINAL CHEMISTRY.
2021.
Uživatel nepovolil zobrazení dat v Portále UP.